Microbial metabolites, short‐chain fatty acids, restrain tissue bacterial load, chronic inflammation, and associated cancer in the colon of mice. Issue 7 (17th May 2018)

• Record Type: Journal Article
• Authors: Kim, Myunghoo; Friesen, Leon; Park, Jeongho; Kim, Hyungjin M.; Kim, Chang H.
• Is Part Of: European journal of immunology. Volume 48:Issue 7(2018)
• Page Start: 1235
• Page End: 1247
• Publication Date: 2018-05-17
• Subjects: Colon cancer -- Dietary fiber -- Inflammation -- Short‐chain fatty acids; Immunology -- Periodicals; 616.079
• DOI: 10.1002/eji.201747122
• Languages: English
• ISSNs: 0014-2980

Abstract

Abstract: The intestinal immune system is regulated by microbes and their metabolites. The roles of gut microbial metabolites in regulating intestinal inflammation and tumorigenesis are incompletely understood. We systematically studied the roles of short‐chain fatty acids (SCFAs) and their receptors (GPR43 or GPR41) in regulating tissue bacterial load, acute versus chronic inflammatory responses, and intestinal cancer development. SCFA receptor‐, particularly GPR43‐, deficient mice were defective in mounting appropriate acute immune responses to promote barrier immunity, and developed uncontrolled chronic inflammatory responses following epithelial damage. Further, intestinal carcinogenesis was increased in GPR43‐deficient mice. Dietary fiber and SCFA administration suppressed intestinal inflammation and cancer in both GPR43‐dependent and independent manners. The beneficial effect of GPR43 was not mediated by altered microbiota but by host tissue cells and hematopoietic cells to a lesser degree. We found that inability to suppress commensal bacterial invasion into the colonic tissue is associated with the increased chronic Th17‐driven inflammation and carcinogenesis in the intestine of GPR43‐deficient mice. In sum, our results reveal the beneficial function of the SCFA‐GPR43 axis in suppressing bacterial invasion and associated chronic inflammation and carcinogenesis in the colon. Abstract : We found with animal models that dietary fiber, their microbial metabolites, and host receptors for these metabolites potentiate gut barrier immune responses during colon cancer development to decrease bacterial burden and chronic inflammatory responses, resulting in decreased cancer formation.